| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |